ClinVar Miner

Submissions for variant NM_000199.5(SGSH):c.416C>T (p.Thr139Met) (rs775112689)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000666794 SCV000791150 uncertain significance Mucopolysaccharidosis, MPS-III-A 2017-05-04 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV001293360 SCV001481815 likely pathogenic Intellectual disability 2021-02-25 criteria provided, single submitter clinical testing The variant chr17-78188504-G-A, SGSH(NM_000199.5):c.416C>T,p.(Thr139Met) was identified in an individual with NDD. Inheritance was not applicable (heterozygous). The variant was reviewed according to current ACMG recommendations and classified as Likely Pathogenic (criteria: PM2_Supporting, PM3_Strong, PP3_Supporting, PP4_Supporting). This variant was identified in a compound heterozygous state with the variantNM_000199.5(SGSH):c.267C>A (p.Tyr89Ter) ( Variation ID: 983123).
Nilou-Genome Lab RCV000666794 SCV002045105 likely pathogenic Mucopolysaccharidosis, MPS-III-A 2021-11-07 criteria provided, single submitter clinical testing
Section for Clinical Neurogenetics,University of Tübingen RCV000666794 SCV001156105 pathogenic Mucopolysaccharidosis, MPS-III-A 2019-08-01 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.